Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept
Author:
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03349.x/fullpdf
Reference47 articles.
1. The EBMT activity survey 2008: impact of team size, team density and new trends;Gratwohl;Bone Marrow Transplant,2011
2. Number of viable CD34(+) cells reinfused predict engraftment in autologous hematopoietic stem cell transplantation;Allan;Bone Marrow Transplant,2002
3. Improving stem cell mobilization strategies: future directions;Bensinger;Bone Marrow Transplant,2009
4. Current status of stem cell mobilization;Gertz;Br J Haematol,2010
5. Defining a therapeutic dose of peripheral blood stem cells;Bender;J Hematother,1992
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation;Transfusion;2024-02-26
2. Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments;Annals of Hematology;2023-03-22
3. Impact of the number of cryopreserved CD34 + cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study;Journal of Clinical Apheresis;2022-10-14
4. The Efficacy and Safety of Plerixafor in Hematopoietic Stem Cell Mobilization in Patients with Non-Hodgkin Lymphoma, Multiple Myeloma, and Hodgkin Lymphoma Who Failed Mobilization with Granulocyte-Colony-Stimulating Factor Alone: A Single-Center Experience;Indian Journal of Medical and Paediatric Oncology;2020-07
5. CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non‐Hodgkinʼs lymphoma patients: results of the prospective multicenter GOA study;Transfusion;2020-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3